CRSP
Crispr Therapeutics AG
57.30$
+3.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 84.4% | 85.6% | 86.9% | 85.9% | 86.2% | 86.4% | 86.2% | 85.4% | 85.9% | 87.2% | 89.8% | 89.5% | |
| 25.3% | 17.5% | 29.0% | 20.7% | 10.0% | 13.3% | 10.9% | 9.7% | 12.9% | 15.7% | 15.5% | 11.0% | |
| 83.4% | 76.0% | 86.4% | 85.5% | 85.8% | 84.9% | 85.7% | 85.0% | 85.3% | 87.2% | 89.6% | 89.2% | |
| – | 9.0% | 0.0% | 0.0% | 0.0% | 1.1% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | |
| 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 17.2% | 15.6% | 14.6% | 15.3% | 14.0% | 13.8% | 15.6% | 15.7% | 14.7% | 15.2% | 33.4% | 34.1% | |
| 5.3% | 4.9% | 4.9% | 5.5% | 4.0% | 3.9% | 5.5% | 5.1% | 5.3% | 6.6% | 5.0% | 5.0% | |
| 0.7% | 0.7% | 0.7% | 0.7% | 0.7% | 0.8% | 0.8% | 0.9% | 0.8% | 0.8% | 0.7% | 0.7% | |
| 1.3% | 1.7% | 0.7% | 0.4% | 0.7% | 0.7% | 0.6% | 0.5% | 0.5% | 0.5% | 0.5% | 0.4% | |
| – | – | – | – | – | – | – | – | – | – | 21.5% | 22.1% | |
| 82.8% | 84.4% | 85.4% | 84.7% | 86.0% | 86.2% | 84.4% | 84.3% | 85.3% | 84.8% | 66.6% | 65.9% | |
| -52.2% | -44.8% | -45.8% | -53.1% | -58.9% | -60.9% | -69.3% | -84.3% | -80.9% | -86.0% | -76.0% | -81.5% | |
| 3.8% | 3.6% | 3.4% | 3.6% | 3.8% | 3.8% | 4.0% | 4.3% | 4.1% | 4.0% | 3.5% | 3.6% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.